Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | United States | $2.85B | 251,924,898 | 35.23% | 64.77% | Net Selling | Net Selling |
| SNTI | SENTI BIOSCIENCES INC | United States | $17.48M | 45,755,021 | 23.95% | 52.51% | ||
| SNGX | SOLIGENIX INC | United States | $6.21M | 15,799,837 | 0.23% | 99.77% | ||
| CGEN | COMPUGEN LTD | Israel | $186.56M | 88,415,382 | 14.22% | 0.00% | ||
| INMB | INMUNE BIO INC | United States | $214.64M | 19,782,429 | 13.85% | 37.05% | Net Buying | Net Buying |
| GNLX | GENELUX CORP | United States | $98.54M | 26,996,740 | 22.29% | 5.19% | Net Selling | Net Selling |
| CYTK | CYTOKINETICS INC | United States | $6.24B | 104,853,918 | 88.53% | 11.47% | Net Selling | Net Selling |
| BNTC | BENITEC BIOPHARMA INC | Australia | $88.90M | 9,367,485 | 13.57% | 10.33% | ||
| LGVN | LONGEVERON INC | United States | $8.13M | 6,348,624 | 0.33% | 99.67% | Net Buying | Net Buying |
| CELU | CELULARITY INC | United States | $58.13M | 19,378,164 | 0.57% | 99.43% | Net Buying | Net Selling |
| GYRE | GYRE THERAPEUTICS INC | United States | $1.22B | 85,510,116 | 0.50% | 99.50% | Net Buying | Net Buying |
| KALV | KALVISTA PHARMACEUTICALS INC | United States | $502.88M | 42,188,296 | 54.17% | 45.83% | Net Buying | |
| CARA | CARA THERAPEUTICS INC | United States | $41.01M | 54,675,954 | 43.18% | 53.39% | Net Selling | Net Selling |
| CMMB | CHEMOMAB THERAPEUTICS LTD | Israel | $11.96M | 284,379,960 | 0.94% | 5.95% | ||
| KOD | KODIAK SCIENCES INC | United States | $173.37M | 52,534,947 | 68.53% | 31.47% | Net Selling | |
| PRTG | PORTAGE BIOTECH INC | Canada | $5.06M | 19,778,000 | 10.84% | 0.00% | ||
| RARE | ULTRAGENYX PHARMACEUTICAL INC | United States | $3.48B | 83,133,341 | 83.24% | 16.76% | Net Selling | Net Selling |
| NEXI | NEXIMMUNE INC | United States | $4.57M | 1,371,051 | 1.97% | 98.03% | Net Selling | |
| PHVS | PHARVARIS NV | Netherlands | $1.10B | 53,816,707 | 78.83% | 0.00% | ||
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS INC | United States | $5.53M | 2,249,290 | 2.45% | 97.55% | Net Buying | |
| GOVX | GEOVAX LABS INC | United States | $3.92M | 2,308,309 | 0.09% | 99.91% | Net Buying | Net Buying |
| SANA | SANA BIOTECHNOLOGY INC | United States | $1.93B | 221,502,908 | 51.17% | 48.83% | Net Buying | Net Selling |
| XTLB | XTL BIOPHARMACEUTICALS LTD | United States | $14.67M | 544,906,149 | 0.05% | 20.78% | ||
| REVB | REVELATION BIOSCIENCES INC | United States | $3.30M | 1,632,935 | 0.08% | 99.92% | Net Selling | |
| KYTX | KYVERNA THERAPEUTICS INC | United States | $664.84M | 43,115,244 | 57.91% | 42.09% | Net Buying | |
| VIRX | VIRACTA THERAPEUTICS INC | United States | $31.69M | 39,272,434 | 3.50% | 96.50% | Net Buying | Net Selling |
| LXEO | LEXEO THERAPEUTICS INC | United States | $456.29M | 32,945,341 | 70.17% | 20.74% | Net Buying | Net Buying |
| ESLA | ESTRELLA IMMUNOPHARMA INC | United States | $36.92M | 36,376,293 | 0.37% | 80.86% | Net Selling | |
| ENSC | ENSYSCE BIOSCIENCES INC | United States | $4.73M | 7,585,172 | 3.95% | 56.03% | ||
| NAMS | NEWAMSTERDAM PHARMA CO NV | Netherlands | $1.81B | 89,976,538 | 63.66% | 36.34% | Net Selling | Net Selling |
| BCDA | BIOCARDIA INC | United States | $10.70M | 27,304,116 | 0.97% | 99.03% | Net Buying | Net Buying |
| EDSA | EDESA BIOTECH INC | Canada | $14.63M | 3,215,968 | 1.26% | 98.74% | Net Buying | Net Buying |
| DARE | DARE BIOSCIENCE INC | United States | $49.03M | 101,092,900 | 6.75% | 25.30% | ||
| NMRA | NEUMORA THERAPEUTICS INC | United States | $1.54B | 159,523,997 | 24.67% | 75.33% | Net Buying | |
| TPST | TEMPEST THERAPEUTICS INC | United States | $70.65M | 22,217,265 | 3.46% | 96.54% | ||
| NVCT | NUVECTIS PHARMA INC | United States | $112.89M | 18,356,060 | 8.51% | 49.28% | Net Buying | Net Buying |
| CRIS | CURIS INC | United States | $69.55M | 5,894,085 | 3.52% | 96.48% | ||
| PROK | PROKIDNEY CORP | United States | $939.54M | 231,698,039 | 11.59% | 36.21% | Net Selling | Net Buying |
| TCBP | TC BIOPHARM (HOLDINGS) PLC | United Kingdom | $5.59M | 98,902,641 | 0.02% | 7.33% | ||
| VERU | VERU INC | United States | $193.23M | 146,383,920 | 32.65% | 33.40% | Net Selling | Net Selling |
| MTNB | MATINAS BIOPHARMA HOLDINGS INC | United States | $42.64M | 250,816,164 | 10.15% | 11.91% | ||
| AVBP | ARRIVENT BIOPHARMA INC | United States | $673.22M | 33,493,750 | 65.24% | 31.26% | Net Buying | |
| APLM | APOLLOMICS INC | United States | $29.71M | 89,495,790 | 10.33% | 0.00% | ||
| ANL | ADLAI NORTYE LTD | United States | $488.44M | 110,700,805 | 0.05% | 0.00% | ||
| MURA | MURAL ONCOLOGY PLC | Ireland | $63.63M | 16,923,878 | 71.45% | 2.66% | ||
| IMNN | IMUNON INC | United States | $13.16M | 9,400,889 | 3.57% | 92.01% | ||
| CRGX | CARGO THERAPEUTICS INC | United States | $804.06M | 39,375,963 | 72.14% | 27.86% | Net Buying | |
| PHIO | PHIO PHARMACEUTICALS CORP | United States | $3.61M | 4,591,700 | 0.12% | 99.88% | Net Buying | Net Buying |
| CLRB | CELLECTAR BIOSCIENCES INC | United States | $118.30M | 35,848,924 | 25.47% | 11.43% | ||
| CKPT | CHECKPOINT THERAPEUTICS INC | United States | $69.28M | 36,850,279 | 14.58% | 8.97% | Net Selling | Net Selling |
| VANI | VIVANI MEDICAL INC | United States | $109.68M | 54,978,465 | 4.37% | 95.63% | Net Buying | |
| ANRO | ALTO NEUROSCIENCE INC | United States | $335.24M | 26,883,990 | 59.01% | 24.97% | Net Buying | Net Buying |
| SLRX | SALARIUS PHARMACEUTICALS INC | United States | $2.36M | 4,776,433 | 1.63% | 98.37% | ||
| VCNX | VACCINEX INC | United States | $8.78M | 1,584,300 | 4.32% | 95.68% | Net Buying | Net Buying |
| CGON | CG ONCOLOGY INC | United States | $2.00B | 66,640,150 | 58.18% | 16.44% | Net Buying | |
| CERE | CEREVEL THERAPEUTICS HOLDINGS INC | United States | $7.67B | 182,194,722 | 26.70% | 73.30% | Net Buying | Net Buying |
| CYBN | CYBIN INC | Canada | $143.93M | 411,216,132 | 76.66% | 0.00% | ||
| CHRO | CHROMOCELL THERAPEUTICS CORP | United States | $10.09M | 5,766,704 | 4.37% | 48.62% | Net Buying | Net Buying |
| SCPX | SCORPIUS HOLDINGS INC | United States | $3.71M | 36,031,964 | 6.16% | 24.28% | ||
| XLO | XILIO THERAPEUTICS INC | United States | $42.08M | 36,912,373 | 29.79% | 68.66% | Net Buying | Net Buying |
| ASMB | ASSEMBLY BIOSCIENCES INC | United States | $80.11M | 5,513,308 | 2.24% | 97.76% | Net Buying | Net Selling |
| INBX | INHIBRX INC | United States | $1.82B | 52,401,941 | 71.38% | 28.62% | Net Buying | |
| CNTX | CONTEXT THERAPEUTICS INC | United States | $150.00M | 74,998,312 | 5.25% | 1.54% | ||
| AKBA | AKEBIA THERAPEUTICS INC | United States | $241.04M | 209,596,378 | 27.21% | 8.82% | Net Selling | Net Selling |
| ICCC | IMMUCELL CORP | United States | $37.58M | 7,811,874 | 12.94% | 24.12% | Net Buying | |
| PTCT | PTC THERAPEUTICS INC | United States | $2.54B | 76,696,785 | 85.81% | 14.19% | Net Selling | Net Selling |
| ADXN | ADDEX THERAPEUTICS LTD | Switzerland | $8.80M | 125,195,393 | 0.00% | 0.00% | ||
| MBIO | MUSTANG BIO INC | United States | $3.90M | 12,514,890 | 5.70% | 20.39% | ||
| KZIA | KAZIA THERAPEUTICS LTD | Australia | $7.43M | 263,615,444 | 0.14% | 8.44% | ||
| SMMT | SUMMIT THERAPEUTICS INC | United Kingdom | $3.12B | 701,979,596 | 7.06% | 92.92% | Net Buying | Net Buying |
| MRSN | MERSANA THERAPEUTICS INC | United States | $334.05M | 122,361,236 | 43.83% | 56.17% | Net Selling | |
| OMER | OMEROS CORP | United States | $199.91M | 57,944,159 | 43.86% | 6.69% | Net Buying | |
| JAGX | JAGUAR HEALTH INC | United States | $76.53M | 295,474,346 | 1.97% | 3.25% | ||
| RNAZ | TRANSCODE THERAPEUTICS INC | United States | $7.62M | 6,622,053 | 5.46% | 52.39% | Net Buying | |
| IKT | INHIBIKASE THERAPEUTICS INC | United States | $11.20M | 6,476,844 | 3.17% | 84.17% | ||
| AVTX | AVALO THERAPEUTICS INC | United States | $9.92M | 1,034,130 | 0.11% | 99.89% | Net Selling | |
| EVAX | EVAXION BIOTECH A | Denmark | $14.10M | 37,897,780 | 1.01% | 0.00% | ||
| TRVN | TREVENA INC | United States | $7.43M | 18,340,953 | 11.24% | 88.76% | Net Buying | |
| CSBR | CHAMPIONS ONCOLOGY INC | United States | $63.89M | 13,593,767 | 1.91% | 98.09% | Net Buying | |
| EYEN | EYENOVIA INC | United States | $40.40M | 53,870,762 | 14.64% | 24.20% | Net Buying | Net Buying |
| CTCX | CARMELL CORP | United States | $42.65M | 20,803,228 | 11.04% | 54.68% | Net Buying | |
| BIVI | BIOVIE INC | United States | $30.02M | 61,018,606 | 10.97% | 78.86% | Net Selling | |
| PSTV | PLUS THERAPEUTICS INC | United States | $12.78M | 5,704,219 | 0.43% | 99.57% | Net Buying | Net Buying |
| INTS | INTENSITY THERAPEUTICS INC | United States | $67.05M | 13,711,877 | 11.91% | 14.62% | ||
| GUTS | FRACTYL HEALTH INC | United States | $338.15M | 47,896,908 | 46.61% | 53.39% | Net Buying | |
| SLS | SELLAS LIFE SCIENCES GROUP INC | United States | $84.32M | 57,754,928 | 13.29% | 13.12% | Net Selling | |
| FNCH | FINCH THERAPEUTICS GROUP INC | United States | $3.12M | 1,605,763 | 0.73% | 99.27% | Net Selling | Net Selling |
| GANX | GAIN THERAPEUTICS INC | United States | $47.48M | 18,051,979 | 10.34% | 1.89% | Net Buying | Net Buying |
| ATXI | AVENUE THERAPEUTICS INC | United States | $3.51M | 940,986 | 14.17% | 85.83% | Net Buying | |
| MGX | METAGENOMI INC | United States | $262.25M | 37,464,201 | 33.76% | 32.96% | Net Buying | |
| MREO | MEREO BIOPHARMA GROUP PLC | United Kingdom | $448.87M | 701,363,484 | 11.98% | 4.58% | ||
| COEP | COEPTIS THERAPEUTICS HOLDINGS INC | United States | $12.99M | 37,118,593 | 12.69% | 39.87% | Net Buying | |
| MLEC | MOOLEC SCIENCE SA | Luxembourg | $45.08M | 37,563,768 | 0.26% | 9.18% | ||
| EPRX | EUPRAXIA PHARMACEUTICALS INC | Canada | $104.73M | 35,622,553 | 0.00% | 0.00% | ||
| NRXS | NEURAXIS INC | United States | $20.05M | 6,594,897 | 1.13% | 39.99% | Net Buying | |
| CING | CINGULATE INC | United States | $4.85M | 6,046,479 | 1.55% | 98.45% | Net Buying | Net Buying |
| ANEB | ANEBULO PHARMACEUTICALS INC | United States | $59.65M | 25,933,217 | 24.91% | 75.09% | ||
| PHGE | BIOMX INC | United States | $18.72M | 55,220,077 | 24.98% | 56.80% | Net Buying | Net Buying |
| BCAB | BIOATLA INC | United States | $136.17M | 48,115,918 | 51.62% | 33.67% | Net Buying | Net Selling |
| TELO | TELOMIR PHARMACEUTICALS INC | United States | $182.99M | 29,609,814 | 0.27% | 16.90% | Net Buying |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.